GOVX's three largest insider shareholders as of September 29, 2026 are John N Jr Spencer (Director, 0 shares), Kelly T. Jr. Mckee (Chief Medical Officer, 0 shares), John W. Sharkey (Vp, Business Development, 0 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Randal D Chase | Director | 0 | 0 | 0 | — | 23 Sep, 2022 |
| 2 | David A Dodd | President, Ceo | 0 | 0 | 0 | — | 01 Apr, 2025 |
| 3 | John N Jr Spencer | Director | 0 | 0 | 0 | — | 20 Oct, 2025 |
| 4 | Mark Reynolds | Cfo | 0 | 0 | 0 | — | 31 Mar, 2025 |
| 5 | John W. Sharkey | Vp, Business Development | 0 | 0 | 0 | — | 10 Apr, 2025 |
| 6 | Kelly T. Jr. Mckee | Chief Medical Officer | 0 | 0 | 0 | — | 08 Aug, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Jun, 2026 | David A Dodd | President, Ceo | Acquired A | 29,300 | $0.00 | $0 | 29,300 | Direct |
| 17 Jun, 2026 | Robert T Mcnally | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Mark J Newman | Chief Scientific Officer | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | John W. Sharkey | Vp, Business Development | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | Randal D Chase | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Kelly T. Jr. Mckee | Chief Medical Officer | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | Dean G Kollintzas | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Mark Reynolds | Cfo | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | John N Jr Spencer | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Jayne Morgan | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Nicole Lemerond | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Oct, 2025 | John N Jr Spencer | Director | Acquired P | 10,000 | $206,164,691,765.41 | $2,061.65Tn | 0 | Direct |
| 07 Aug, 2025 | Kelly T. Jr. Mckee | Chief Medical Officer | Acquired P | 1,107 | $251,237,438,128.09 | $278.12Tn | 0 | Direct |
| 05 Jun, 2025 | Robert T Mcnally | Director | Acquired A | 10,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | Mark J Newman | Chief Scientific Officer | Acquired A | 70,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | Mark Reynolds | Cfo | Acquired A | 70,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | Jayne Morgan | Director | Acquired A | 10,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | Nicole Lemerond | Director | Acquired A | 10,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | John N Jr Spencer | Director | Acquired A | 10,000 | $0.00 | $0 | 0 | Direct |
| 05 Jun, 2025 | John W. Sharkey | Vp, Business Development | Acquired A | 70,000 | $0.00 | $0 | 0 | Direct |